Cargando…
Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
Osteoprotegerin (OPG) is a secreted member of the tumor necrosis factor (TNF) receptor superfamily that has been well characterized as a negative regulator of bone remodeling. OPG is also expressed in human breast cancer tissues and cell lines. In vitro studies suggest that OPG exerts tumor-promotin...
Autores principales: | Weichhaus, Michael, Segaran, Prabu, Renaud, Ashleigh, Geerts, Dirk, Connelly, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302663/ https://www.ncbi.nlm.nih.gov/pubmed/24976340 http://dx.doi.org/10.1002/cam4.277 |
Ejemplares similares
-
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells
por: Chung, Stephanie Tsang Mui, et al.
Publicado: (2017) -
Osteoprotegerin in breast cancer: beyond bone remodeling
por: Weichhaus, Michael, et al.
Publicado: (2015) -
Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
por: Geerts, Dirk, et al.
Publicado: (2020) -
LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2018) -
EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry
por: Luan, Haitao, et al.
Publicado: (2023)